<DOC>
	<DOCNO>NCT00358566</DOCNO>
	<brief_summary>To investigate efficacy GV1001 sequential combination gemcitabine locally advance metastatic adenocarcinoma pancreas .</brief_summary>
	<brief_title>GV1001 Gemcitabine Sequential Combination Gemcitabine Monotherapy Pancreatic Cancer</brief_title>
	<detailed_description>The trial Phase III , multinational , multicentre , control , randomise open-label trial . It involve 520 advanced pancreatic cancer patient . Patients randomly assign receive Gemcitabine alone GV1001 plus GM-CSF follow addition Gemcitabine time 1st progression disease . The experimental treatment give prior current standard treatment 50 % patient .</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<criteria>1 . Histologically cytologically confirm , unresectable , locally advanced , metastatic adenocarcinoma pancreas . 2 . Adequate hematological parameter : Hemoglobin &gt; /= 9.5 g/dL [ SI unit , 5.9 mmol/L ] WBC &gt; /= 3000/mm3 [ SI unit , &gt; /= 3 x 109/L ] Platelets &gt; /= 100,000/mm3 [ SI unit , &gt; /= 100 x 109/L ] 3 . Adequate baseline liver function : Total Bilirubin &lt; 3x ULN Without liver metastasis : AST ( SGOT ) &lt; /= 2.5 x ULN ALT ( SGPT ) &lt; /= 2.5 x ULN With liver metastasis : AST ( SGOT ) &lt; /= 5 x ULN ALT ( SGPT ) &lt; /= 5 x ULN 4 . Serum creatinine &lt; /= 1.5 mg/dL [ SI unit , 132 Âµmol/L ] . 5 . Performance status ECOG 01 . 6 . Male female 18 75 year inclusive . 7 . Minimum life expectancy 3 month . 8 . Written informed consent . 1 . Treatment chemotherapy pancreatic cancer . 2 . Treatment investigational drug within last 4 week prior inclusion 3 . Immunesuppressive therapy &lt; 4 week prior inclusion 4 . Chronic corticosteroid use except asthma inhaler / topical use 5 . Radiotherapy within 8 week randomisation . 6 . Other prior malignancy except adequately treat nonmelanoma skin cancer ( BCC , SCC ) carcinoma situ cervix . 7 . Known diagnosis HIV ( AIDS ) , Hepatitis B , C. 8 . Known history coexist autoimmune disease . 9 . Known CNS metastasis . 10 . Clinically significant serious disease organ system disease currently control present therapy . 11 . Pregnancy lactation . 12 . Women childbearing potential use reliable adequate contraceptive methods* 13 . Known sensitivity component vaccine , gemcitabine GMCSF . 14 . Unable reason comply protocol ( treatment assessment ) . Adequate contraceptive method define use oral , implanted , injectable , mechanical barrier product prevention pregnancy ; woman practise abstinence ; partner sterile , example vasectomy .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Advanced</keyword>
	<keyword>Unresesctable</keyword>
	<keyword>Adenocarcinoma</keyword>
	<keyword>Pancreatic cancer</keyword>
</DOC>